Criteria for Continuous Kidney Replacement Therapy Cessation in ICU Patients.


Journal

Blood purification
ISSN: 1421-9735
Titre abrégé: Blood Purif
Pays: Switzerland
ID NLM: 8402040

Informations de publication

Date de publication:
2023
Historique:
received: 16 09 2021
accepted: 04 03 2022
pubmed: 20 4 2022
medline: 1 2 2023
entrez: 19 4 2022
Statut: ppublish

Résumé

In intensive care unit (ICU) patients with acute kidney injury, specific recommendations to guide the decision to cease continuous kidney replacement therapy (CKRT) are lacking. We performed a survey to identify criteria currently used to cease CKRT in real-life clinical practice in the Netherlands. We used an online questionnaire with multiple choice questions designed with web-based software from SurveyMonkey. We received 169 completed questionnaires from intensivists (n = 126) and nephrologists (n = 43). Essential determinants for the cessation of CKRT were a spontaneously increasing diuresis (indicated by 92% of the respondents), absence of fluid overload (indicated by 88% of the respondents), and improvement in creatinine clearance (indicated by 61% of the respondents; intensivists 56%; nephrologists 77%, p = 0.03). Most often mentioned cut-off values used for increase in diuresis were 0.25 and 0.5 mL/kg/h (35% and 33%, respectively). Actual CKRT cessation was often postponed until the filter clots or until circuit disconnection is needed because of patient transport for diagnostic or intervention procedures (indicated by 58% of the respondents). Expected discharge from the ICU was the most frequently reported determinant to switch from CKRT to hemodialysis (indicated by 67% of the respondents). CKRT cessation in clinical practice is mostly based on spontaneously increasing diuresis, absence of fluid overload, and improvement in creatinine clearance and is often delayed until filter clotting or disconnection of the circuit because of logistic reasons.

Identifiants

pubmed: 35439755
pii: 000524180
doi: 10.1159/000524180
pmc: PMC9909622
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-40

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Références

Kidney Int Suppl (2011). 2012 Mar;2(1):89-115
pubmed: 25018921
Nephrol Dial Transplant. 2006 May;21(5):1248-52
pubmed: 16449291
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
J Crit Care. 2012 Dec;27(6):744.e1-5
pubmed: 23102534
JAMA. 2016 May 24-31;315(20):2190-9
pubmed: 27209269
Blood Purif. 2019;48(1):10-17
pubmed: 30844791
Crit Care. 2018 Oct 10;22(1):255
pubmed: 30305122
Ann Intensive Care. 2016 Dec;6(1):71
pubmed: 27443673
Lancet. 2020 May 9;395(10235):1506-1515
pubmed: 32334654
Semin Dial. 2011 Mar-Apr;24(2):164-8
pubmed: 21517982
Intensive Care Med. 2001 Jun;27(6):1037-43
pubmed: 11497136
Kidney Blood Press Res. 2018;43(3):872-881
pubmed: 29870981
N Engl J Med. 2008 Jul 3;359(1):7-20
pubmed: 18492867
Intensive Care Med. 2008 Jan;34(1):101-8
pubmed: 17701162
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
Crit Care. 2020 Feb 13;24(1):50
pubmed: 32054522
BMC Nephrol. 2019 Apr 15;20(1):129
pubmed: 30987604
J Cardiothorac Surg. 2012 Jan 18;7:6
pubmed: 22257468
Crit Care Med. 2009 Sep;37(9):2576-82
pubmed: 19623048
N Engl J Med. 2016 Jul 14;375(2):122-33
pubmed: 27181456
Kidney Int. 2015 Oct;88(4):897-904
pubmed: 26154928
Crit Care Med. 2009 Feb;37(2):533-8
pubmed: 19114909
J Crit Care. 2018 Jun;45:144-148
pubmed: 29477939
Nephrology (Carlton). 2019 Mar;24(3):287-293
pubmed: 29717547

Auteurs

Meint Volbeda (M)

Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Martha Oord (M)

Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jacqueline Koeze (J)

Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Eric Keus (E)

Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Iwan C C van der Horst (ICC)

Department of Intensive Care Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.

Casper F M Franssen (CFM)

Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH